{"literatureAnnotation":{"id":1445584717,"history":[{"id":1445584718,"date":"2015-08-17T13:37:18.646-07:00","type":"create","version":0}],"literature":{"id":15091552,"resourceId":"25999454","title":"Inherited genetic variation in childhood acute lymphoblastic leukemia.","authors":["Moriyama Takaya","Relling Mary V","Yang Jun J"],"journal":"Blood","month":6,"page":"3988-95","pubDate":"2015-06-01T00:00:00-07:00","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/25999454","summary":"Although somatically acquired genomic alterations have long been recognized as the hallmarks of acute lymphoblastic leukemia (ALL), the last decade has shown that inherited genetic variations (germline) are important determinants of interpatient variability in ALL susceptibility, drug response, and toxicities of ALL therapy. In particular, unbiased genome-wide association studies have identified germline variants strongly associated with the predisposition to ALL in children, providing novel insight into the mechanisms of leukemogenesis and evidence for complex interactions between inherited and acquired genetic variations in ALL. Similar genome-wide approaches have also discovered novel germline genetic risk factors that independently influence ALL prognosis and those that strongly modify host susceptibility to adverse effects of antileukemic agents (eg, vincristine, asparaginase, glucocorticoids). There are examples of germline genomic associations that warrant routine clinical use in the treatment of childhood ALL (eg, TPMT and mercaptopurine dosing), but most have not reached this level of actionability. Future studies are needed to integrate both somatic and germline variants to predict risk of relapse and host toxicities, with the eventual goal of implementing genetics-driven precision-medicine approaches in ALL treatment.","type":"article","volume":"125","xrefs":[{"id":1449290203,"resource":"PubMed","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/25999454","xrefId":"25999454"},{"id":1449290205,"resource":"Digital Object Identifiers","sameAs":"http://dx.doi.org/10.1182%2Fblood-2014-12-580001","xrefId":"10.1182/blood-2014-12-580001"},{"id":1449290204,"resource":"PubMed Central","sameAs":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481591","xrefId":"PMC4481591"}],"year":2015},"relatedObjects":[{"objCls":"Gene","id":"PA24446","symbol":"ACP1","name":"acid phosphatase 1, soluble"},{"objCls":"Gene","id":"PA25052","symbol":"ASNS","name":"asparagine synthetase (glutamine-hydrolyzing)"},{"objCls":"Gene","id":"PA26122","symbol":"CBR3","name":"carbonyl reductase 3"},{"objCls":"Gene","id":"PA142672125","symbol":"CEP72","name":"centrosomal protein 72kDa"},{"objCls":"Gene","id":"PA28586","symbol":"GATA3","name":"GATA binding protein 3"},{"objCls":"Gene","id":"PA28966","symbol":"GRIA1","name":"glutamate receptor, ionotropic, AMPA 1"},{"objCls":"Gene","id":"PA29196","symbol":"HAS3","name":"hyaluronan synthase 3"},{"objCls":"Gene","id":"PA35072","symbol":"HLA-DRB1","name":"major histocompatibility complex, class II, DR beta 1"},{"objCls":"Gene","id":"PA29790","symbol":"IL15","name":"interleukin 15"},{"objCls":"Gene","id":"PA134963132","symbol":"NUDT15","name":"nudix (nucleoside diphosphate linked moiety X)-type motif 15"},{"objCls":"Gene","id":"PA33129","symbol":"PDE4B","name":"phosphodiesterase 4B, cAMP-specific"},{"objCls":"Gene","id":"PA134865839","symbol":"SLCO1B1","name":"solute carrier organic anion transporter family, member 1B1"},{"objCls":"Gene","id":"PA356","symbol":"TPMT","name":"thiopurine S-methyltransferase"},{"objCls":"Disease","id":"PA446155","name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma"},{"objCls":"Chemical","id":"PA130620651","name":"anthracyclines and related substances"},{"objCls":"Chemical","id":"PA448492","name":"asparaginase"},{"objCls":"Chemical","id":"PA448515","name":"azathioprine"},{"objCls":"Chemical","id":"PA450379","name":"mercaptopurine"},{"objCls":"Chemical","id":"PA450428","name":"methotrexate"},{"objCls":"Chemical","id":"PA451663","name":"thioguanine"},{"objCls":"Chemical","id":"PA451879","name":"vincristine"}]},"publication":{"id":15091552,"resourceId":"25999454","title":"Inherited genetic variation in childhood acute lymphoblastic leukemia.","authors":["Moriyama Takaya","Relling Mary V","Yang Jun J"],"journal":"Blood","month":6,"page":"3988-95","pubDate":"2015-06-01T00:00:00-07:00","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/25999454","summary":"Although somatically acquired genomic alterations have long been recognized as the hallmarks of acute lymphoblastic leukemia (ALL), the last decade has shown that inherited genetic variations (germline) are important determinants of interpatient variability in ALL susceptibility, drug response, and toxicities of ALL therapy. In particular, unbiased genome-wide association studies have identified germline variants strongly associated with the predisposition to ALL in children, providing novel insight into the mechanisms of leukemogenesis and evidence for complex interactions between inherited and acquired genetic variations in ALL. Similar genome-wide approaches have also discovered novel germline genetic risk factors that independently influence ALL prognosis and those that strongly modify host susceptibility to adverse effects of antileukemic agents (eg, vincristine, asparaginase, glucocorticoids). There are examples of germline genomic associations that warrant routine clinical use in the treatment of childhood ALL (eg, TPMT and mercaptopurine dosing), but most have not reached this level of actionability. Future studies are needed to integrate both somatic and germline variants to predict risk of relapse and host toxicities, with the eventual goal of implementing genetics-driven precision-medicine approaches in ALL treatment.","type":"article","volume":"125","xrefs":[{"id":1449290203,"resource":"PubMed","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/25999454","xrefId":"25999454"},{"id":1449290205,"resource":"Digital Object Identifiers","sameAs":"http://dx.doi.org/10.1182%2Fblood-2014-12-580001","xrefId":"10.1182/blood-2014-12-580001"},{"id":1449290204,"resource":"PubMed Central","sameAs":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481591","xrefId":"PMC4481591"}],"year":2015},"related":{"GENE":[{"objCls":"Gene","id":"PA24446","symbol":"ACP1","name":"acid phosphatase 1, soluble"},{"objCls":"Gene","id":"PA25052","symbol":"ASNS","name":"asparagine synthetase (glutamine-hydrolyzing)"},{"objCls":"Gene","id":"PA26122","symbol":"CBR3","name":"carbonyl reductase 3"},{"objCls":"Gene","id":"PA142672125","symbol":"CEP72","name":"centrosomal protein 72kDa"},{"objCls":"Gene","id":"PA28586","symbol":"GATA3","name":"GATA binding protein 3"},{"objCls":"Gene","id":"PA28966","symbol":"GRIA1","name":"glutamate receptor, ionotropic, AMPA 1"},{"objCls":"Gene","id":"PA29196","symbol":"HAS3","name":"hyaluronan synthase 3"},{"objCls":"Gene","id":"PA35072","symbol":"HLA-DRB1","name":"major histocompatibility complex, class II, DR beta 1"},{"objCls":"Gene","id":"PA29790","symbol":"IL15","name":"interleukin 15"},{"objCls":"Gene","id":"PA134963132","symbol":"NUDT15","name":"nudix (nucleoside diphosphate linked moiety X)-type motif 15"},{"objCls":"Gene","id":"PA33129","symbol":"PDE4B","name":"phosphodiesterase 4B, cAMP-specific"},{"objCls":"Gene","id":"PA34068","symbol":"PYGL","name":"phosphorylase, glycogen, liver"},{"objCls":"Gene","id":"PA134865839","symbol":"SLCO1B1","name":"solute carrier organic anion transporter family, member 1B1"},{"objCls":"Gene","id":"PA356","symbol":"TPMT","name":"thiopurine S-methyltransferase"}],"DISEASE":[{"objCls":"Disease","id":"PA445187","name":"Osteonecrosis"},{"objCls":"Disease","id":"PA446155","name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma"}],"CHEMICAL":[{"objCls":"Chemical","id":"PA130620651","name":"anthracyclines and related substances"},{"objCls":"Chemical","id":"PA448492","name":"asparaginase"},{"objCls":"Chemical","id":"PA448515","name":"azathioprine"},{"objCls":"Chemical","id":"PA450379","name":"mercaptopurine"},{"objCls":"Chemical","id":"PA450428","name":"methotrexate"},{"objCls":"Chemical","id":"PA451663","name":"thioguanine"},{"objCls":"Chemical","id":"PA451879","name":"vincristine"}]},"relationships":[{"id":1445584701,"history":[],"literature":[{"id":15091552,"resourceId":"25999454","title":"Inherited genetic variation in childhood acute lymphoblastic leukemia.","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/25999454","type":"article"}],"object1s":[{"objCls":"Gene","id":"PA28586","symbol":"GATA3","name":"GATA binding protein 3"},{"objCls":"Gene","id":"PA29790","symbol":"IL15","name":"interleukin 15"},{"objCls":"Gene","id":"PA33129","symbol":"PDE4B","name":"phosphodiesterase 4B, cAMP-specific"},{"objCls":"Gene","id":"PA34068","symbol":"PYGL","name":"phosphorylase, glycogen, liver"},{"objCls":"Gene","id":"PA356","symbol":"TPMT","name":"thiopurine S-methyltransferase"}],"object2s":[{"objCls":"Disease","id":"PA446155","name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma"}],"operator1":"and","operator2":"and","related":true,"terms":[{"id":769229934,"resource":"Phenotype Categories","term":"efficacy","termId":"secondaryCat:769229934"}]},{"id":1445584703,"history":[],"literature":[{"id":15091552,"resourceId":"25999454","title":"Inherited genetic variation in childhood acute lymphoblastic leukemia.","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/25999454","type":"article"}],"object1s":[{"objCls":"Gene","id":"PA134963132","symbol":"NUDT15","name":"nudix (nucleoside diphosphate linked moiety X)-type motif 15"},{"objCls":"Gene","id":"PA356","symbol":"TPMT","name":"thiopurine S-methyltransferase"}],"object2s":[{"objCls":"Chemical","id":"PA448515","name":"azathioprine"},{"objCls":"Chemical","id":"PA450379","name":"mercaptopurine"},{"objCls":"Chemical","id":"PA451663","name":"thioguanine"}],"operator1":"and","operator2":"and","related":true,"terms":[{"id":769229935,"resource":"Phenotype Categories","term":"toxicity","termId":"secondaryCat:769229935"}]},{"id":1445584705,"history":[],"literature":[{"id":15091552,"resourceId":"25999454","title":"Inherited genetic variation in childhood acute lymphoblastic leukemia.","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/25999454","type":"article"}],"object1s":[{"objCls":"Gene","id":"PA24446","symbol":"ACP1","name":"acid phosphatase 1, soluble"}],"object2s":[{"objCls":"Disease","id":"PA445187","name":"Osteonecrosis"}],"operator1":"and","operator2":"and","related":true,"terms":[{"id":769229935,"resource":"Phenotype Categories","term":"toxicity","termId":"secondaryCat:769229935"}]},{"id":1445584707,"history":[],"literature":[{"id":15091552,"resourceId":"25999454","title":"Inherited genetic variation in childhood acute lymphoblastic leukemia.","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/25999454","type":"article"}],"object1s":[{"objCls":"Gene","id":"PA25052","symbol":"ASNS","name":"asparagine synthetase (glutamine-hydrolyzing)"},{"objCls":"Gene","id":"PA28966","symbol":"GRIA1","name":"glutamate receptor, ionotropic, AMPA 1"},{"objCls":"Gene","id":"PA35072","symbol":"HLA-DRB1","name":"major histocompatibility complex, class II, DR beta 1"}],"object2s":[{"objCls":"Chemical","id":"PA448492","name":"asparaginase"}],"operator1":"and","operator2":"and","related":true,"terms":[{"id":769229935,"resource":"Phenotype Categories","term":"toxicity","termId":"secondaryCat:769229935"}]},{"id":1445584709,"history":[],"literature":[{"id":15091552,"resourceId":"25999454","title":"Inherited genetic variation in childhood acute lymphoblastic leukemia.","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/25999454","type":"article"}],"object1s":[{"objCls":"Gene","id":"PA26122","symbol":"CBR3","name":"carbonyl reductase 3"},{"objCls":"Gene","id":"PA29196","symbol":"HAS3","name":"hyaluronan synthase 3"}],"object2s":[{"objCls":"Chemical","id":"PA130620651","name":"anthracyclines and related substances"}],"operator1":"and","operator2":"and","related":true,"terms":[{"id":769229935,"resource":"Phenotype Categories","term":"toxicity","termId":"secondaryCat:769229935"}]},{"id":1445584711,"history":[],"literature":[{"id":15091552,"resourceId":"25999454","title":"Inherited genetic variation in childhood acute lymphoblastic leukemia.","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/25999454","type":"article"}],"object1s":[{"objCls":"Gene","id":"PA142672125","symbol":"CEP72","name":"centrosomal protein 72kDa"}],"object2s":[{"objCls":"Chemical","id":"PA451879","name":"vincristine"}],"operator1":"and","operator2":"and","related":true,"terms":[{"id":769229935,"resource":"Phenotype Categories","term":"toxicity","termId":"secondaryCat:769229935"}]},{"id":1445584713,"history":[],"literature":[{"id":15091552,"resourceId":"25999454","title":"Inherited genetic variation in childhood acute lymphoblastic leukemia.","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/25999454","type":"article"}],"object1s":[{"objCls":"Gene","id":"PA134865839","symbol":"SLCO1B1","name":"solute carrier organic anion transporter family, member 1B1"}],"object2s":[{"objCls":"Chemical","id":"PA450428","name":"methotrexate"}],"operator1":"and","operator2":"and","related":true,"terms":[{"id":769229935,"resource":"Phenotype Categories","term":"toxicity","termId":"secondaryCat:769229935"}]},{"id":1445584715,"history":[],"literature":[{"id":15091552,"resourceId":"25999454","title":"Inherited genetic variation in childhood acute lymphoblastic leukemia.","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/25999454","type":"article"}],"object1s":[{"objCls":"Gene","id":"PA134865839","symbol":"SLCO1B1","name":"solute carrier organic anion transporter family, member 1B1"}],"object2s":[{"objCls":"Chemical","id":"PA450428","name":"methotrexate"}],"operator1":"and","operator2":"and","related":true,"terms":[{"id":981344088,"resource":"Phenotype Categories","term":"metabolism/PK","termId":"secondaryCat:981344088"}]}]}